First Participant Dosed in First-in-Human Phase 1 Study of GZC8072, a Novel Ultra-Long-Acting Once-Weekly Oral Peptide GLP-1 RA BEIJING and BRIDGEWATER, Mass., Sept. 9, 2026 /PRNewswire/ — Gan&Lee Pharmaceuticals Co.,… CISION PRNewswireSeptember 9, 2026
Yuyu Pharma CEO Robert Wonsang Yu Launches "Robert's YUniverse" Podcast SEOUL, South Korea, Sept. 9, 2026 /PRNewswire/ — Robert Wonsang Yu, CEO… CISION PRNewswireSeptember 9, 2026
Press ReleaseMoonwalk Biosciences Announces $70 Million Series B: NYSE Content Update NYSE issues a pre-market daily advisory direct from the trading floor. NEW… CISION PRNewswireSeptember 9, 2026
Press ReleaseClinical Psychologist Urges Women to Recognise the Signs of a Dysregulated Nervous System MELBOURNE, Australia, Sept. 9, 2026 /PRNewswire/ — Women are becoming increasingly skilled… CISION PRNewswireSeptember 9, 2026
COLE HAAN LAUNCHES "COMFORTABLE ANYWHERE" CAMPAIGN STARRING CHRISTIAN SLATER AND JENNY SLATE Cole Haan’s fall 2026 global campaign is about staying comfortable, confident and… CISION PRNewswireSeptember 9, 2026
Leifras Continues to Operate Nagoya City's Nagoya Club Activities Human Resources Bank, Addressing Instructor Shortage Three-Year Contract — Platform Supporting Elementary Schools’ "New Sports and Cultural Activities"… CISION PRNewswireSeptember 9, 2026
Press ReleaseAULUMU Wins Yanko Design Best of IFA 2026, Showcases Award-Winning Tech Gear in Berlin BERLIN, Sept. 9, 2026 /PRNewswire/ — AULUMU, a design brand focused on… CISION PRNewswireSeptember 9, 2026
Full-Life Technologies Announces U.S. FDA IND Clearance and Australian Regulatory Clearance for [²²⁵Ac]Ac-FL-261 Phase 1 Clinical Trial LONDON, Sept. 9, 2026 /PRNewswire/ — Full-Life Technologies ("Full-Life", the "Company"), a… CISION PRNewswireSeptember 9, 2026
